University Hospitals Cleveland Medical Center will collaborate with Qure.ai on a clinical trial to study the use of AI-powered X-ray for the early detection of lung cancer.
The study will compare the AI tool’s ability to detect pulmonary nodules on chest X-rays alongside radiologists’ interpretations, according to an April 2 news release from the health system.
“The clinical trial will evaluate how many patients require follow-up CT scans, biopsies, and how many more lung cancer cases are diagnosed earlier using AI,” Amit Gupta, MD, division chief of cardiothoracic imaging and modality director of diagnostic radiography at UH Cleveland Medical Center, said in the release. “The hope is that this clinical trial will not only advance early detection but also drive meaningful transformation in lung cancer surveillance.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
